Ankylosing spondylitis and risk of ischaemic heart disease: A population-based cohort study

Annals of the Rheumatic Diseases

Volumn 75, Issue 1, 2016, Pages 203-209

  Essers, Ivette ^a,b,c   Stolwijk, Carmen ^a,b,c   Boonen, Annelies ^b,c   De Bruin, Marie L ^a   Bazelier, Marloes T ^a   De Vries, Frank ^a,b,c,d   Van Tubergen, Astrid ^b,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; CLINICAL TRIAL; COMPLICATION; DRUG UTILIZATION; FACTUAL DATABASE; GREAT BRITAIN; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PREVALENCE; PROCEDURES; SPONDYLITIS, ANKYLOSING; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 84954214141     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206147     Document Type: Article

References (26)

1. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med 2013;369:448-57.
2. Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722-32.
3. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.
4. Peters MJ, Symmons DP, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010;69:325-31.
5. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33:1635-701.
6. Mathieu S, Motreff P, Soubrier M. Spondyloarthropathies: an independent cardiovascular risk factor? Joint Bone Spine 2010;77:542-5.
7. Bremander A, Petersson IF, Bergman S, et al. Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (Hoboken) 2011;63:550-6.
8. Han C, Robinson DW Jr, Hackett MV, et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006;33:2167-72.
9. Szabo SM, Levy AR, Rao SR, et al. Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum 2011;63:3294-304.
10. Mathieu S, Gossec L, Dougados M, et al. Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011;63:557-63.
11. Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, et al. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585-92.
12. Peters MJ, Visman I, Nielen MM, et al. Ankylosing spondylitis: a risk factor for myocardial infarction? Ann Rheum Dis 2010;69:579-81.
13. Sukenik S, Pras A, Buskila D, et al. Cardiovascular manifestations of ankylosing spondylitis. Clin Rheumatol 1987;6:588-92.
14. Brophy S, Cooksey R, Atkinson M, et al. No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis-a retrospective cohort study using routine data. Semin Arthritis Rheum 2012;42:140-5.
15. de Vries F, Abbing-Karahagopian V. Ankylosing spondylitis and myocardial infarction: a true association or selection bias? Ann Rheum Dis 2010.
16. Huang YP, Wang YH, Pan SL. Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis-a population-based longitudinal follow-up study. PLoS ONE 2013;8:e64155.
17. Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013;382:769-79.
18. Agency EM. New safety advice for diclofenac. New measures aim to minimise cardiovascular risks. 2013. [updated 25 September; cited 10 December 2013]. http://www.ema.europa.eu/docs/en-GB/document-library/Referrals-document/Diclofenac-containing-medicinal-products/European-Commission-final-decision/WC500155819.pdf
19. McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006;296:1633-44.
20. Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010;69:4-14.
21. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2014. 2014. [updated 19 December 2013; cited 2 October 2014]. http://www.whocc.no/atc-ddd-index/
22. Fosslien E. Cardiovascular complications of non-steroidal anti-inflammatory drugs. Ann Clin Lab Sci 2005;35:347-85.
23. Tournadre A, Pereira B, Lhoste A, et al. Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohort. Arthritis Care Res (Hoboken) 2013;65:1482-9.
24. Slobodin G, Reyhan I, Avshovich N, et al. Recently diagnosed axial spondyloarthritis: gender differences and factors related to delay in diagnosis. Clin Rheumatol 2011;30:1075-80.
25. Herrett E, Shah AD, Boggon R, et al. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ 2013;346:f2350.
26. Tam LS, Shang Q, Kun EW, et al. The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis-a randomized, placebo-controlled pilot trial. Rheumatology (Oxford) 2014;53:1065-74.